As shown in Fig. 1, Fig. 2B, the GAG content was increased by BMP-4 supplementation at concentrations of 2 ​nM or higher in both NP (P ​< ​0.001) and AF pellets (P ​< ​0.001). The gene discussed is BMP4; the disease is atrial fibrillation.